Search Results - A. P. Pereverzev
- Showing 1 - 20 results of 26
- Go to Next Page
-
1
EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION by S. K. Zyryanov, A. P. Pereverzev
Published 2017-07-01Atrial fibrillation (AF) is one of the most prevalent rhythm disorders and might be associated with the high risk of thromboembolic complications, including stroke. For risk estimation, of the thrombotic complications, a variety of scores has been implemented, including CHA2DS2-VASc Score. According...
Get full text
Article -
2
Drug-Induced Fatty Liver Disease by A. P. Pereverzev, O. D. Ostroumova
Published 2020-06-01Drug-induced fatty liver disease (DIFLD) covers a group of adverse drug reactions whose prevalence accounts for about 10% of all adverse reactions. The aim of this review was to analyse and summarise data on medicines that can potentially lead to the development of DIFLD, as well as on the pathophys...
Get full text
Article -
3
THE LABELLING OF THE CONTAINERS FOR STORAGE AND TRANSPORTATION OF MEDICINAL PRODUCTS by A. P. Pereverzev, B. K. Romanov
Published 2018-02-0115-25% of cases of the medicatiom errors caused by the similarity in spelling or pronunciation of their names. The labelling may be a means of protection against such errors. The authors proposed a way of marking that is applied to each unit product information protective barcode labels containing i...
Get full text
Article -
4
Modern methods of identification of adverse events associated with medication errors by A. P. Pereverzev, S. K. Zyryanov, Y. Sh. Guschina
Published 2018-02-01Prevention of adverse events caused by medication errors is an important challenge of modern healthcare as it offers the possibility to reduce mortality, improve patient safety and reduce costs arosed from correction of complications. Two modern methods (Global Trigger Tool and Failure Mode and Effe...
Get full text
Article -
5
Good Pharmacovigilance Practice in the United States and the European Union by V. A. Merkulov, N. D. Bunyatyan, A. P. Pereverzev
Published 2022-06-01The article presents the results of a comparative analysis of Goodpharmacovigilance practices (GVP), developed by experts of the regulatory bodiesof the European Union (EU) and the United States. It is shown that the EU GVP cover almost all possible aspects of pharmacovigilance. It is noted that the...
Get full text
Article -
6
COMPARATIVE EVALUATION OF INFORMATION ON ADVERSE REACTIONS TO MEDICINES by V. K. Lepakhin, A. P. Pereverzev, B. K. Romanov
Published 2018-02-01Comparative evaluation of information about adverse reactions to medicinal products was carried out on the basis of the research data registered in specialized databases WHO, Russia, Switzerland, USA and the Republic of Kazakhstan. Comparative evaluation of the results of safety monitoring medicines...
Get full text
Article -
7
Complications of Pharmacotherapy with New Oral Anticoagulants Caused by Inter-Drug Interactions: Focus on Gastrointestinal Bleeding by A. P. Pereverzev, O. D. Ostroumova, O. N. Tkacheva, Yu. V. Kotovskaya
Published 2019-06-01New oral anticoagulants are effective for the prevention of thromboembolic complications in patients with atrial fibrillation, or after orthopedic surgery. The use of these drugs may be associated with the risk of bleeding from the gastrointestinal tract — a dangerous complication, which can...
Get full text
Article -
8
Malnutrition in Elderly Patients as a Complication of a Drug Therapy: Clinical Pharmacologist’s Point of View by A. P. Pereverzev, O. N. Tkacheva, Y. V. Kotovskaya, O. D. Ostroumova
Published 2019-03-01Malnutrition is a patient’s condition with high relevance and importance for elderly patients (most often seen in very old patients >80 years old), since it is associated with a high risk of progressive worsening of their state, prolongation of hospitalization and death. Exposure to some drug...
Get full text
Article -
9
ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS by R. N. Alyautdin, A. P. Pereverzev, B. K. Romanov, N. D. Bunyatyan
Published 2022-06-01In this article authors analyze the influence of a label on drugpackage on the risk of medication errors and propose methods of their prevention.Analysis of the corresponding data published by regulators EMA and FDA hasprovided an opportunity to find examples of phonetic and graphic similaritieswith...
Get full text
Article -
10
Changes in the legal protection of inventions in the Russian Federation by A. A. Elapov, A. P. Pereverzev, N. D. Bunyatyan, I. V. Borisevich
Published 2018-02-01This article provides the analysis of the updated versions of the existing legislative framework, regulating legal relations in the state registration of intellectual property. It considers expert views on the mentioned issue and provides with certain recommendations that are reasonable to be taken...
Get full text
Article -
11
On the safety of acetaminophen by R. N. Alyautdin, V. K. Lepakhin, B. K. Romanov, A. P. Pereverzev
Published 2022-06-01Acetaminophen is one of the most commonly used analgesics /anti pyretics. However, taking into account the existing risk of hepatotoxicity,regulatory bodies of a number of the countries made additional adjustments tothe recommendations on the use of this drug. In the article the possible reasonsfor...
Get full text
Article -
12
Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia by A. P. Pereverzev, O. D. Ostroumova, O. N. Tkacheva, Y. V. Kotovskaya
Published 2019-12-01For the treatment of dementia and Alzheimer’s disease, acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) and/or the non-competitive inhibitor of N-methyl-D-aspartate receptors (NMDA receptors) memantine are currently used. The administration of these drugs can help temporarily i...
Get full text
Article -
13
Revisiting the Safety of Vaccination against the Flu in Elderly Patients by O. N. Tkacheva, A. P. Pereverzev, N. K. Runikhina, Yu. V. Kotovskaya
Published 2018-12-01Abstract. Elderly patients are at higher risk of developing infectious diseases that might have more severe progression than those of younger age groups, accompanied by an increased risk of death. These medical conditions in elderly may also present difficulties for diagnosis due to a «blurred» clin...
Get full text
Article -
14
Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs by E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
Published 2016-11-01The effectiveness of antiarrhythmic drugs in the elderly is similar to that in younger patients. However data for «the very elderly» are lacking. Elderly patients are more vulnerable to adverse drug reactions (ADRs) because of age-related changes of pharmacokinetics, co-morbidity and drug interactio...
Get full text
Article -
15
Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs by E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
Published 2016-09-01Use of class I antiarrhythmic drugs in the elderly is limited by their adverse drug reactions (ADRs), proarrhythmic effect (I A и I C) and high risk of drug interactions. Disopyramide use should be avoided due to its strong anticholinergic properties associated with the risk of cognitive and physica...
Get full text
Article -
16
Qualitative methods of benefit / risk assessment by A. P. Pereverzev, A. N. Mironov, N. D. Bunyatyan, V. K. Lepakhin, B. K. Romanov
Published 2022-06-01In this article authors describe some existing methods of benefit / risk assessment.
Get full text
Article -
17
USE OF DRUGS DURING THE FIRST TRIMESTER OF PREGNANCY IN TERMS OF FOETUS SAFETY: ANALYSIS OF PRESCRIBINGS by A. P. Pereverzev, A. N. Mironov, N. D. Bunyatyan, V. K. Lepakhin, B. K. Romanov
Published 2022-06-01The article presents the results of analysis of the use of drugs in the first trimester of pregnancy from the point of view of safety to the fetus
Get full text
Article -
18
LOCAL ANESTHETIC MYOTOXICITY by B. K. Romanov, A. P. Pereverzev, A. N. Mironov, N. D. Bunyatyan, V. K. Lepakhin
Published 2022-05-01The article presents the mechanisms of development and methods of correction of myotoxicity associated with use of local anesthetics
Get full text
Article -
19
Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors by O. D. Ostroumova, E. A. Volkova, A. I. Kochetkov, A. P. Pereverzev, O. N. Tkacheva
Published 2019-11-01The review addresses the issue of the gastrointestinal bleeding (GIB) development in patients receiving oral anticoagulants, and the proton pump inhibitors (PPIs) efficiency in reducing of such complications. Epidemiological data on the prevalence of GIB in the presence of nonwarfarin oral anticoagu...
Get full text
Article -
20
Non-pharmacological Approaches to Treatment of Patients over 60 Years as a Way to Improve Pharmacotherapy Safety and Prevent Polypharmacy by A. P. Pereverzev, O. N. Tkacheva, Yu. V. Kotovskaya, Yu. S. Onuchina, E. N. Dudinskaya, A. V. Naumov
Published 2018-12-01Abstract. The demographic aging of the population of the earth observed in recent years is associated, inter alia, with the advent of new effective and safe medicines. However, the availability of highly effective drugs on the market also has a reverse side — the appearance of adverse drug reactions...
Get full text
Article